M88 game APK Assists Ambrx Biopharma in its Listing on the New York Stock Exchange
2021.07.03
On June 18, 2021, Ambrx Biopharma Inc. ("Ambrx Biopharma", stock ticker: AMAM) made an initial offering of American Depositary Shares ("ADSs") and listed on M88 game APK New York Stock Exchange. Ambrx Biopharma offered 7,000,000 ADSs (excluding overallotment rights) at an offering price of USD per share, raising total funds of USD 6 million.
Ambrx Biopharma, headquartered in San Diego, California, is a clinical-stage biopharmaceutical research and development company. M88 game APK company uses extended genetic cryptography technology to develop engineered biologicals, including antibody-drug conjugate (ADC), immunomodulatory proteins, bispecific antibodies, and oM88 game APKr modified M88 game APKrapeutic proteins.
M88 game APK acts as the PRC counsel to the underwriters Goldman Sachs, BofA Securities and Cowen in this project and conducted legal due diligence, and reviewed and revised the application and offering documents relating to this offering for Ambro Biopharma’s PRC subsidiaries and onshore R&D cooperation projects.
M88 game APK lead partner of this project was Mr.M88 Game 关于我们.
